Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical azithromycin for prevention of Lyme borreliosis after tick bite
2011-000117-39Phase 3Completed
- Sponsor
- Ixodes
- Start
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Lyme borreliosis comparing SHB004 topical azithromycin with Placebo (2 arms). Primary endpoint: Treatment failure within the ITT set at Day 57. Started Apr 2011; status: completed.
02
Drugs
azithromycin
03
Conditions
Lyme borreliosis
Beyond the preview
Go deeper on 2011-000117-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000117-39.